Icoria

Icoria was a biotechnology company specializing in functional genomics, proteomics, and metabolomics to accelerate drug discovery and development. Originally established as Paradigm Genetics, the company utilized its proprietary GeneFunction Factory and metabolomics platforms to identify biomarkers and therapeutic targets for complex diseases. Icoria's approach integrated high-throughput biological data with advanced bioinformatics to provide insights into gene function and biochemical pathways. The company served both the healthcare and agricultural sectors, forming significant partnerships with organizations like Monsanto and the National Cancer Institute. In 2005, Icoria was acquired by Clinical Data, Inc., integrating its discovery technologies into a broader personalized medicine and molecular diagnostics portfolio.